HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert V Gibbons Selected Research

Hepatitis E

9/2013A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).
3/2008Hepatitis E: a neglected threat.
10/2006Hepatitis E antibody kinetics in Nepalese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert V Gibbons Research Topics

Disease

28Dengue (Dengue Fever)
01/2019 - 04/2007
24Infections
01/2018 - 04/2007
7Human Influenza (Influenza)
10/2018 - 06/2010
7Fever (Fevers)
12/2013 - 03/2008
6Japanese Encephalitis
03/2015 - 07/2007
4Severe Dengue
08/2016 - 04/2007
4Coinfection
09/2015 - 04/2007
4Viremia
07/2014 - 03/2008
3Hepatitis E
09/2013 - 10/2006
2Encephalitis (Encephalitis, Rasmussen)
09/2013 - 09/2010
2Acute Febrile Encephalopathy
09/2013 - 07/2012
2Leptospirosis
08/2010 - 12/2007
1Acute Pain
01/2018
1Shock
08/2016
1Necrosis
08/2014
1Virus Diseases (Viral Diseases)
08/2014
1Hepatitis A (Hepatitis, Infectious)
09/2013
1Exanthema (Rash)
01/2013
1Meningitis
07/2012
1Central Nervous System Infections (Central Nervous System Infection)
07/2012
1Chickenpox
08/2011
1Convalescence
01/2011
1Reinfection
09/2008
1Hepatitis
03/2008
1Rabies (Hydrophobia)
05/2002
1Bites and Stings (Sting)
05/2002

Drug/Important Bio-Agent (IBA)

20VaccinesIBA
01/2019 - 10/2006
12Immunoglobulin M (IgM)IBA
02/2015 - 10/2006
8EnzymesIBA
09/2013 - 07/2007
7Neutralizing AntibodiesIBA
05/2016 - 03/2008
7ImmunosorbentsIBA
09/2013 - 07/2007
6AntigensIBA
08/2014 - 07/2007
4Immunoglobulin G (IgG)IBA
02/2015 - 11/2007
4AntibodiesIBA
08/2013 - 11/2007
3Dengue VaccinesIBA
01/2019 - 09/2013
3Viral RNAIBA
01/2018 - 03/2009
3RNA (Ribonucleic Acid)IBA
01/2018 - 12/2013
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2016 - 11/2007
3EpitopesIBA
09/2015 - 01/2011
2Antiviral Agents (Antivirals)IBA
01/2018 - 03/2015
2Influenza Vaccines (Influenza Vaccine)FDA Link
02/2016 - 01/2015
2Proteins (Proteins, Gene)FDA Link
11/2011 - 09/2008
2Capsid Proteins (Capsid Protein)IBA
03/2008 - 10/2006
1Hemagglutinins (Hemagglutinin)IBA
10/2018
1Analgesics (Analgesic Drugs)IBA
01/2018
1Combined VaccinesIBA
03/2017
1Immune Sera (Antisera)IBA
09/2015
1HLA-B44 AntigenIBA
09/2015
1ProteomeIBA
09/2015
13-nitrotyrosineIBA
08/2014
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2014
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2014
1Japanese Encephalitis VaccinesIBA
09/2013
1AIDS VaccinesIBA
09/2013
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
09/2013
1Neurofibromin 2 (Merlin)IBA
12/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2011
1ORALIT (ORS)IBA
07/2011
1Pharmaceutical PreparationsIBA
07/2011
1HLA-A Antigens (HLA-A)IBA
01/2011
1STAT1 Transcription FactorIBA
10/2009
1InterferonsIBA
10/2009
1Explosive Agents (Explosives)IBA
03/2008
1Recombinant ProteinsIBA
03/2008
1Serum AlbuminIBA
12/2007
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2007
1ABO Blood-Group SystemIBA
04/2007
1Blood Group Antigens (Blood Groups)IBA
04/2007
1AerosolsIBA
05/2002

Therapy/Procedure

1Resuscitation
08/2016